drugset / Trial / NCT03605680
A Trial Evaluating the Efficacy, Safety, & Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
This study evaluates the efficacy, safety, and tolerability of centanafadine sustained-release tablets in adults with attention-deficit/hyperactivity disorder (ADHD). Participants will either receive a twice-daily dose of centanafadine sustained-release tablets, or twice-daily placebo.
Timeline
- Start
- 2019-01-16
- Primary completion
- 2020-04-11
- Completion
- 2020-04-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Centanafadine | Small molecule | 100 mg | Oral |
| Subject | Centanafadine | Small molecule | 200 mg | Oral |